Global Radiotherapy (External (IGRT, IMRT, 3D-CRT, Stereotactic), & Brachytherapy (LDR, HDR)) Market Report 2018-2023

Dublin, Jan. 21, 2019 (GLOBE NEWSWIRE) -- The "Radiotherapy Market by Type, Brachytherapy, Product, Application, End User - Forecasts to 2023" report has been added to ResearchAndMarkets.com's offering.

The global radiotherapy market is projected to reach USD 6,778.5 million by 2023 from USD 5,550.1 million in 2018, at a CAGR of 4.1% from 2018 to 2023.

Market growth is largely driven by factors such as technological advancements, the rising prevalence of cancer, the increasing number of conferences and symposia focusing on spreading awareness about the benefits of radiotherapy, and the growing use of particle therapy for cancer treatment. The emerging markets, growing government and private investments to meet the increasing demand for cancer treatment, and the improving reimbursement scenario are expected to present a wide range of growth opportunities for market players.

On the other hand, lack of adequate healthcare infrastructure, shortage of trained personnel, affordability and accessibility of treatment, and the complex nature of radiotherapy are expected to limit market growth to a certain extent. Difficulties in visualizing tumors during radiotherapy procedures and the risk of radiation exposure may also pose challenges to market growth in the coming years.

North America is expected to account for the largest share of the radiotherapy market in 2018, followed by Europe. The large share of this segment is attributed to factors such as technological advancements in radiotherapy equipment, growing number of cancer cases, increasing number of radiotherapy centers, and presence of major players in this region.

The Asia Pacific market, on the other hand, is expected to offer high growth opportunities for market players during the forecast period. In 2018, Asia Pacific is expected to account for a share of 23.5% of the radiotherapy market. This regional segment is expected to register the highest CAGR of 6.2% from 2018 to 2023.

Factors such as growing medical tourism, increasing initiatives to promote the use of advanced radiotherapy technologies, and focus of global players on enhancing their presence in the emerging nations (such as China and India) of the region are supporting the growth of the radiotherapy market in the Asia Pacific.

In order to sustain their dominance in the radiotherapy industry, a majority of prominent players are increasingly focusing on acquiring smaller players to increase their geographical presence and strengthen their product portfolios. In addition to product development and acquisitions, increasing penetration in the high-growth Asia Pacific market will prove to be an effective growth strategy for companies focusing on increasing their shares in the global radiotherapy market.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Radiotherapy Market Overview
4.2 Europe: External Radiotherapy Market, By Type, 2018
4.3 Internal Beam Radiotherapy/Brachytherapy Market, By Product Type
4.4 External Beam Radiotherapy Market, By Application
4.5 Regional Analysis: Radiotherapy Market, By End User
4.6 Radiotherapy Market, By Country

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Technological Advancements
5.2.1.2 Rising Prevalence of Cancer
5.2.1.3 Increasing Number of Conferences and Symposia Focusing on Spreading Awareness About the Benefits of Radiotherapy
5.2.1.4 Growing Use of Particle Therapy for Cancer Treatment
5.2.2 Restraints
5.2.2.1 Lack of Adequate Healthcare Infrastructure
5.2.2.2 Shortage of Trained Personnel
5.2.2.3 Affordability and Accessibility of Treatment
5.2.2.4 Complex Nature of Radiotherapy
5.2.3 Opportunities
5.2.3.1 Emerging Markets
5.2.3.2 Growing Government and Private Investments to Meet the Increasing Demand for Cancer Treatment
5.2.3.3 Improving Reimbursement Scenario
5.2.4 Challenges
5.2.4.1 Difficulties in Visualizing Tumors During Radiotherapy Procedures
5.2.4.2 Risk of Radiation Exposure
5.3 Industry Trends
5.3.1 Growing Adoption of Pencil-Beam Scanning
5.3.2 Growing Number of Collaborations and Acquisitions

6 Radiotherapy Market, By Product Type
6.1 Introduction
6.2 External Beam Radiotherapy
6.2.1 Linear Accelerators
6.2.1.1 Conventional Linear Accelerators
6.2.1.1.1 Lower Equipment and Maintenance Cost Will Drive the Market for Conventional Linacs
6.2.1.2 Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators
6.2.1.2.1 Automation and Real-Time Tracking Features Have Ensured Demand for Stereotactic Advanced Linac
6.2.1.2.2 Gamma Knife
6.2.1.2.3 Cyberknife
6.2.1.2.4 Tomotherapy
6.2.1.2.4.1 360-Degree (Helical) Radiation Treatment With Tomotherapy is Adding Growth Opportunities to This Segment
6.2.2 Particle Therapy Systems
6.2.2.1 Cyclotrons
6.2.2.1.1 Leading Players in the Particle Therapy Market Mainly Manufacture Cyclotrons
6.2.2.2 Synchrotrons
6.2.2.2.1 Increasing Investment for the Development of Synchrotron Facilities are Contributing to Market Growth
6.2.2.3 Synchrocyclotrons
6.2.2.3.1 High Space Requirements of Synchrocyclotrons are Limiting Its Widespread Adoption
6.2.3 Conventional Cobalt-60 Teletherapy Units
6.2.3.1 High Cost and Risk of Radiation Exposure With Cobalt-60 Radioisotopes Have Hindered the Growth of This Segment
6.3 Internal Beam Radiotherapy/Brachytherapy
6.3.1 Seeds
6.3.1.1 Adverse Side-Effects Associated With Seeds Limit Their Adoption
6.3.2 Applicators
6.3.2.1 Manual Applicators Pose A High Risk of Radiation Exposure to the Patients and Staff
6.3.3 Afterloaders
6.3.3.1 Modern Afterloaders Offer Proper Positioning and Better Control of Isotopes Inside the Patient Body
6.3.4 Electronic Brachytherapy Products
6.3.4.1 Electronic Brachytherapy Requires Low Amount of Shielding Than Alternatives
6.4 Systemic Radiotherapy
6.4.1 Iobenguane (I-131)
6.4.1.1 Increasing Incidence of Thyroid Cancer is Driving the Growth of This Segment
6.4.2 Samarium-153
6.4.2.1 Samarium-153 has Wide Applications for Bone Metastasis
6.4.3 Rhenium-186
6.4.3.1 Lack of Insurance Coverage With the Use of Rhenium-186 Restricting Its Growth
6.4.4 Other Systemic Radiotherapy Products

7 Radiotherapy Market, By Type
7.1 Introduction
7.2 External Beam Radiotherapy
7.2.1 Image-Guided Radiotherapy
7.2.1.1 Image-Guided Radiotherapy is Widely Used to the Treatment of Deep-Seated Tumors
7.2.2 3d Conformal Radiotherapy
7.2.2.1 Multiple Beams With 3d-Crt Allow Precise Radiation Conforming to the Tumor Size and Shape
7.2.3 Intensity-Modulated Radiotherapy
7.2.3.1 Volumetric Arc Therapy
7.2.3.1.1 Advancements in the Vmat Technology Driving Its Widespread Adoption
7.2.3.2 Tomotherapy
7.2.3.2.1 Minimal Exposure to Normal Tissues - A Major Advantage of Tomotherapy
7.2.4 Stereotactic Therapy
7.2.4.1 Stereotactic Therapy Offers A Minimally Invasive Alternative to Ablation Surgeries
7.2.5 Particle Therapy
7.2.5.1 Particle Therapy is Increasingly Being Adopted as A Primary Mode of Treatment for Various Cancer Types
7.3 Internal Beam Radiotherapy
7.3.1 Low-Dose-Rate Brachytherapy
7.3.1.1 Lower Risk of Radiation Exposure to the Surrounding Tissues With Ldr Supporting Market Growth
7.3.2 High-Dose-Rate Brachytherapy
7.3.2.1 Better Patient Care With HDR is Driving Its Widespread Adoption
7.3.3 Pulsed-Dose-Rate Brachytherapy
7.3.3.1 Pulsed-Dose Rate Brachytherapy Combines the Advantages of HDR and Ldr Brachytherapy
7.4 Systemic Radiotherapy
7.4.1 Intravenous Radiotherapy
7.4.1.1 Intravenous Route of Brachytherapy Results in Maximum Bioavailability
7.4.2 Oral Radiotherapy
7.4.2.1 Longer Distribution Time Associated With the Oral Mode of Radiation Delivery Limiting Its Demand
7.4.3 Instillation Radiotherapy
7.4.3.1 Lesser Localization With Instillation Brachytherapy is Limiting Its Widespread Adoption

8 Radiotherapy Market, By Application
8.1 Introduction
8.2 External Beam Radiation Therapy
8.2.1 Prostate Cancer
8.2.1.1 High Incidence of Prostate Cancer Will Drive the Demand for Ebrt
8.2.2 Breast Cancer
8.2.2.1 Adoption of Advanced Ebrt Systems and Increasing Research Will Drive Market Growth
8.2.3 Lung Cancer
8.2.3.1 Radiotherapy Can Be Used as Solo Or Combination Therapy for Lung Cancer
8.2.4 Head and Neck Cancer
8.2.4.1 Benefits of External Radiotherapy Will Support Its Use in Head and Neck Cancer Treatment
8.2.5 Colorectal Cancer
8.2.5.1 Availability of Alternative Therapeutic Options Limits the Growth of This Segment
8.2.6 Other Cancers
8.3 Internal Beam Radiotherapy/Brachytherapy
8.3.1 Prostate Cancer
8.3.1.1 Rapidity and Precision of Brachytherapy in Prostate Cancer Treatment Have Driven Market Growth
8.3.2 Gynecological Cancer
8.3.2.1 Availability of Alternatives Hinders the Adoption of Brachytherapy in Gynecological Cancer Treatment
8.3.3 Breast Cancer
8.3.3.1 Precision and Rapid Treatment Times are Driving the Use of Brachytherapy in Breast Cancer Applications
8.3.4 Cervical Cancer
8.3.4.1 A Combination of Brachytherapy and Chemotherapy is Typically Used for Cervical Cancer Treatment
8.3.5 Penile Cancer
8.3.5.1 Advantages of Brachytherapy in Penile Cancer Treatment Have Driven Its Adoption
8.3.6 Other Cancers

9 Radiotherapy Market, By End User
9.1 Introduction
9.1.1 Hospitals
9.1.1.1 Increasing Number of Small-Footprint Advanced Radiotherapy Products Promoting Their Adoption in Hospitals
9.1.2 Independent Radiotherapy Centers
9.1.2.1 Rising Consolidation of Healthcare Networks is Challenging the Growth of Freestanding Radiotherapy Centers

10 Radiotherapy Market, By Region
10.1 Introduction
10.2 North America
10.2.1 US
10.2.1.1 Growing Government Initiatives Boosting the Adoption of Radiotherapy in the Us
10.2.2 Canada
10.2.2.1 Rising Cancer Incidence Driving the Demand for Radiotherapy in Canada
10.3 Europe
10.3.1 Germany
10.3.1.1 Increasing Awareness of Novel and Advanced Radiotherapy Products A Key Factor Contributing to Market Growth
10.3.2 France
10.3.2.1 Growing Government Initiatives Boosting the Adoption of Radiotherapy in France
10.3.3 UK
10.3.3.1 Leading Market Players Focusing on Expanding Their Product Offerings in the Uk
10.3.4 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.1.1 Presence of A Large Number of Local Manufactures Supporting the Growth of the Radiotherapy Market in China
10.4.2 Japan
10.4.2.1 Rising Prevalence of Cancer is Driving the Adoption of Radiotherapy in Japan
10.4.3 India
10.4.3.1 Shortage of Skilled Radiotherapy Professionals in India is Restraining Market Growth
10.4.4 Rest of Asia Pacific
10.5 Rest of the World

11 Competitive Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Competitive Scenario
11.4 Vendor Dive Overview
11.5 Vendor Inclusion Criteria
11.6 Vendor Dive

12 Company Profiles

• Accuray Incorporated
• C.R.Bard, Inc.
• Elekta
• Hitachi, Ltd.
• IBA (Ion Beam Applications Sa)
• Ion Beam Applications SA
• Isoray Medical, Inc.
• Mevion Medical Systems, Inc.
• Optivus Proton Therapy, Inc.
• P-Cure Ltd.
• Panacea Medical Technologies Pvt. Ltd.
• Provision Healthcare, LLC.
• Sumitomo Heavy Industries, Ltd
• Theragenics Corporation
• Varian Medical Systems, Inc.
• Viewray Inc.

For more information about this report visit https://www.researchandmarkets.com/research/m5ltp6/global?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

                    CONTACT: ResearchAndMarkets.com
                             Laura Wood, Senior Press Manager
                             press@researchandmarkets.com
                             For E.S.T Office Hours Call 1-917-300-0470
                             For U.S./CAN Toll Free Call 1-800-526-8630
                             For GMT Office Hours Call +353-1-416-8900
                    Related Topics: Nuclear Medicine and Radiopharmacology